|
A Prospective Observational Study on of Early-Onset Gastrointestinal Cancer: From Tumor Features to Patient Lifestyle Habits
RECRUITINGSponsored by Gruppo Oncologico Italiano di Ricerca Clinica
Actively Recruiting
SponsorGruppo Oncologico Italiano di Ricerca Clinica
Started2026-07-30
Est. completion2028-04
Eligibility
Age18 Years – 49 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07479472
Summary
The YOGICO study aims to characterize the distinctive features of EoGI cancer through a holistic approach that integrates clinical and demographic data, tumor biological characteristics, and patient lifestyle habits
Eligibility
Age: 18 Years – 49 YearsHealthy volunteers accepted
Inclusion Criteria: * Provide a signed and dated informed consent form (ICF) * Willing to comply with all study procedures and be available for the duration of the study * Male or female, aged 18-49 years old at time of EoGI cancer diagnosis * Patients with newly diagnosed early-onset gastrointestinal cancer histologically confirmed: colorectal, gastroesophageal and pancreatic tumor site, regardless of histological type * Any disease stage, performance status, and type of treatment, including experimental therapies and supportive care * Previous or concomitant malignancies are allowed provided they do not involve the gastrointestinal tract Exclusion Criteria: * Cognitive, linguistic, or physical barriers that prevent a detailed reconstruction of the patient's personal medical history including past lifestyle habits * Having previously received any treatments directed at the newly diagnosed EOGI cancer (i.e., at the time of inclusion, the patient has not yet started any type of treatment, excluding surgery)
Conditions2
CancerEarly-onset Gastrointestinal Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorGruppo Oncologico Italiano di Ricerca Clinica
Started2026-07-30
Est. completion2028-04
Eligibility
Age18 Years – 49 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07479472